Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q3 2023 ▲▼ | Q4 2023 ▲▼ | Change ▲▼ | Q3 2023 ▲▼ | Q4 2023 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| LYELL IMMUNOPHARMA INC(LYEL) | 20,162,332 | 20,162,332 | 0 | 29,639 | 39,115 | 32.90% | +9,476 |
| BEAM THERAPEUTICS INC(BEAM) | 2,346,934 | 2,346,934 | 0 | 56,444 | 63,884 | 53.74% | +7,440 |
| PRIME MEDICINE INC(PRME) | 1,792,210 | 1,792,210 | 0 | 17,098 | 15,879 | 13.36% | -1,219 |